Medicus Pharma Ltd MDCX
0.15
(0.01)
(6.25%)
as of 25 Sep
- Market cap
- $10.0M
- P/E
- 0.0×
Follow MDCX
| Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|
Current Ratio |
0.02 | 2.42 | 2.33 | 1.00 |
Net Debt/EBITDA |
0.27 | 0.36 | 0.37 | 0.25 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.62 | 0.78 | 0.92 | 0.48 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 |
| 0.00% | 95.88% | (525.45%) | (2,981.87%) | |
| 0.00% | (488.54%) | (295.90%) | (602.13%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
13.87% | (478.16%) | (363.12%) | 99,562.95% |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(0.28) | (1.20) | (1.07) | (1.32) |
Cash per Share |
0.07 | 0.49 | 0.43 | 0.50 |
Shareholders Equity per Share |
(3.24) | 0.32 | 0.33 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(3.24) | 0.32 | 0.33 | 0.00 |
Free Cash Flow |
(1.06) | (4.16) | (10.25) | (22.78) |
Working Capital |
(12.20) | 1.11 | 3.07 | (0.05) |
Net Current Asset Value |
(12.20) | 1.11 | 2.87 | (0.13) |
| Other line items | ||||
Quick Ratio |
0.02 | 2.20 | 1.81 | 0.88 |
Cash ROIC |
8.86% | (146.90%) | (140.39%) | (260.53%) |
Accounts Payable Turnover |
— | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.28) | (1.20) | (1.07) | (1.32) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Average Payables |
— | 0.16 | 0.75 | 2.36 |
Average Assets |
— | 1.09 | 3.77 | 7.85 |
Average Common Equity |
— | (5.54) | 2.12 | 1.59 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates